The Center for Biotechnology and Interdisciplinary Studies was buzzing with activity over the summer, with more than 200 undergraduate and graduate students conducting research that will impact the global challenges facing humanity. In the lab of Douglas Swank, associate professor of biological sciences, researchers are using Drosophila (commonly known as the fruit fly) as a model organism to unravel some of the biggest mysteries of the human heart.
What gives music its appeal? Why does one composition enthrall and endure, while another falls flat? Internationally recognized composer and researcher Gareth Loy will share his findings on October 25, during “A Theory of Musical Interest,” the keynote address of the Art_x Symposium of Music, Sound, and Mathematics at Rensselaer.
To bolster the connections between benchside and bedside, the National Institutes of Health National Institute on Aging has awarded Rensselaer Polytechnic Institute a five-year $1.5 million training grant to support a new Alzheimer’s Disease Clinical and Translational Research Training Program.
New work from the School of Architecture that explores sustainable building practices, new design and fabrication strategies, architectural acoustics, and the integration of new technologies will be showcased at the World Maker Faire New York.
Rensselaer Polytechnic Institute ranks among the best universities in the United States, according to the annual list of college rankings released this week by U.S. News & World Report.
Rensselaer alumnus and former CEO and co-founder of YuMe Jayant Kadambi ’85, M.S. ’86, selected as Entrepreneur of the Year.
The fourth annual Rensselaer Research Showcase on August 23 offered government and private sector research partners an opportunity to learn more about insights emerging from research in biotechnology and the life sciences, and the current climate for the biopharmaceutical economy that work supports.
Four Rensselaer students have been selected to attend the 10th annual Clinton Global Initiative University this fall.
A synthetic version of low molecular weight heparin is poised for clinical trials and development as a drug for patients with clotting disorders, and those undergoing procedures such as kidney dialysis, heart bypass surgery, stent implantation, and knee and hip replacement.
The Friends of the Folsom Library at Rensselaer have announced the third Carl A. Westerdahl Forum, which will take place Monday, Sept. 11, on the Troy campus. The program will feature a dialogue with Rensselaer archivist Jen Monger and Erica Wagner, author of the recent biography Chief Engineer: Washington Roebling, The Man Who Built the Brooklyn Bridge, published by Bloomsbury.